Comparison of continuous medication versus intermittent medication through regional anaesthetic technique in breast cancer patients undergoing surgery
Not Applicable
Completed
- Conditions
- Health Condition 1: C508- Malignant neoplasm of overlappingsites of breast
- Registration Number
- CTRI/2019/08/020751
- Lead Sponsor
- AIIMS
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
Patients with breast cancer scheduled for unilateral modified radical mastectomy.
ASA I-II patients.
Patient consenting for study.
Exclusion Criteria
Patients refusing to participate.
Patients with history of coagulopathy.
Patients on anticoagulant therapy with deranged INR or aPTT values.
Patients with history of known allergy to local anaesthetics and other induction agent drugs.
Patients with local site infection.
Patients with BMI >35 kg/m2
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Postoperative opioid consumption after Erector Spinae block. <br/ ><br>Timepoint: At 24hours <br/ ><br>
- Secondary Outcome Measures
Name Time Method Assessment of Quality of recovery by QOR-15 questionnaire <br/ ><br>Timepoint: at 24 hours.;Catheter related complicationsTimepoint: 24 hours;Dermatomal sensory mappingTimepoint: at 30 minutes and 24 hours after block (by 3 point -scale).;Incidence of Postoperative nausea and vomiting. <br/ ><br>Timepoint: 24 hours;Intraoperative fentanyl consumption. <br/ ><br>Timepoint: From induction of anaesthesia to reversal of neuromuscular blockade;Numeric Pain Rating Scale scoreTimepoint: 0,1,2,4,6,12,24 hours;Patient satisfactionTimepoint: 24 hours;Time to first bolus of rescue analgesic by PCA pump.Timepoint: at time of request of rescue analgesic by patient